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VIDEOS B PANCREAS/BILIARY
CV-B.01 COMPLETION RADICAL
CHOLECYSTECTOMY AND PORTAL
LYMPHADENECTOMY: MINIMALLY
INVASIVE TECHNIQUES FOR
MANAGEMENT OF INCIDENTAL
GALLBLADDER CARCINOMA
S. Lee, M. I. DAngelica, W. R. Jarnagin and T. P. Kingham
Memorial Sloan-Kettering Cancer Center, New York, NY –
NEW YORK
Introduction: Gallbladder cancers staged T1b or higher are
treated with a liver resection and portal lymphadenectomy.
Methods: We present 2 patients and their surgical videos to
illustrate our experience. The patients had preoperative
staging imaging and index pathology was reviewed. Diag-
nostic laparoscopy was performed prior to proceeding with
liver resection and lymphadenectomy. A 30-degree laparo-
scope, bipolar, surgical staples and harmonic scalpel were
used to perform the segment 4b/5 liver resection and portal
lymphadenectomy. The use of the da Vinci Surgical
System(Si system, Intuitive Surgical Inc., Sunnyvale, CA)
was illustrated in one case. Frozen section and intraoperative
ultrasonography assisted in determining extent of resection.
Results: Four patients underwent a prior laparoscopic cholecys-
tectomy at an external institution with an incidental diagnosis of
T1b or higher gallbladder adenocarcinoma were treated with a
minimally invasive approach for completion radical cholecystec-
tomy and portal lymphadenectomy. After a staging CT scan to
exclude metastatic disease, a laparoscopic/robotic portal
lymphadenectomy, frozen section of the cystic duct remnant and
segment 4b/5 liver wedge resection was performed. The mean
estimated blood loss was 150 cc (range: 50 to 400 cc), operative
time was 225 minutes (range: 165 to 290 mins), length of stay was
5 days (range: 4 to 7 days) and there were no complications. The
mediannumberof lymphnodesharvestedwas6andtherewereno
residual cancer seen in resected liver segment 4b/5 in all the cases.
Conclusion: A minimally invasive approach to early gall-
bladder cancers can be safely utilized to perform a comple-
tion radical cholecystectomy and portal lymphadenectomy.
CV-B.02 SURGICAL ASPECTS OF THE
MESENTERICOPORTAL VENOUS
RESECTION IN
HEPATO-BILIO-PANCREATIC SURGERY
E. Vicente, Y. Quijano, B. Ielpo, H. Duran, E. Diaz,
I. Fabra, C. Oliva, S. Olivares, R. Caruso, R. Ceron,
A. Cubillo and J. Plaza
Sanchinarro University Hospital, Madrid, MADRID
Neoplasm of the hepatobiliopancreatic (HPB) field may be
deemed locally unresectable because they appear to encase
the superior mesenteric vessels. Limited data exist on the
ability of high-quality contrast-enhanced CT to accurately
predict the need for venous resection at the time of resection.
Intra-operative evaluation of the relationship of a tumor of
the superior mesenteric vein (SMV) or portal vein is prone to
inaccuracy. SMV resection and reconstruction at the time of
HPB tumors add significant complexity to an already lengthy
operation. However, with proper patient selection and
surgeon experience, SMV resection and reconstruction can
be performed safely. The need of venous resection does not
significantly impact survival duration. The video show a
variety of methods for venous resection and reconstruction.
CV-B.03 PANCREATIC
NEUROENDOCRINE TUMOR WITH
CELIAC AXIS INVOLVEMENT
V. M. Cano Busnelli, F. A. Alvarez and J. Pekolj
HPB Surgery Section And Liver Transplant Unit. Hospital
Italiano De Buenos Aires., Capital Federal, CAPITAL
FEDERAL
Introduction: Pancreatic neuroendocrine tumors (PNETs)
are rare neoplasms. Complete surgical resection is the only
curative treatment and remains the cornerstone therapy for
these patients. Surgically aggressive approaches have resulted
in improved long-term survival in locally advanced disease.
Methods: We present a 41-year-old male with diagnosis of a
pancreatic neuroendocrine tumor of the body and tail that was
biopsed during elective open cholecystectomy. Chromogranin
and synaptophysin were positive and the Ki67 was 60%. A
CT-scan revealed compromise of the celiac axis and the posterior
gastric wall. Selective common hepatic artery embolization was
performed to increase flow to the Proper Hepatic artery via the
Gastroduodenal artery.Apreoperative angiography certified flow
on the Proper Hepatic Artery from the pancreatoduodenal
arcades from the Superior Mesenteric artery. A distal espleno-
pancreatectomy with en bloc total gastrectomy, transverse
colectomy and celiac axis resection was carried out. Digestive
reconstruction was accomplished with a circular stapled Roux-
en-Y esophagojejunostomy. A linear stapler was used for duode-
nal and pancreatic section.
Results: The patient developed a duodenal fistula that did
not require further treatment rather than a longer hospital
stay. The histo-pathological report confirmed a neuro-
endocrine origin.
Conclusion: The presented Appleby operation was feasible
and safe in experienced hands with satisfactory results. In
patients with tumoral involvement of the celiac axis, preop-
erative embolization of the hepatic artery offers the possibil-
ity to achieve complete tumor removal; therefore offering a
chance of cure to patients previously declared unresectable.
CV-B.04 LAPAROSCOPIC COMMON
BILE DUCT EXPLORATION FOR
IMPACTED CHOLEDOCHOLITHIASIS
S. Jayaraman
University Of Toronto, Toronto, ON – ONTARIO
The indications for common bile duct exploration are limited
with the widespread availability of endoscopic retrograde
cholangiopancreatography (ERCP). However, in selected
cases, surgical clearance of choledocholithiasis is necessary
due to anatomic factors or failed ERCP. This video demon-
strates the case of an elderly woman with several medical
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comorbidities. She had ERCP with stent insertion and
papillotomy for a bile duct that was impacted with gallstones.
Dozens of stones were removed endoscopically at that time;
however, a second ERCP was performed due to recurrent
jaundice and symptoms. The first stent had migrated and the
duct was still impacted despite removing even more stones.
She was referred for laparoscopic common bile duct explo-
ration. This video demonstrates all of the steps required for
total clearance of the common duct in a challenging case:
duct exposure, choledochotomy, stone and stent extraction,
complete choledochoscopy and stone extraction, duct
closure, cholecystectomy, and cholangiography. A T-tube
was not inserted at the conclusion of the operation as the
patient had a recent papillotomy and her anatomy was normal
(no Roux-en-Y).
CV-B.05 LAPAROSCOPIC PARTIAL
SLEEVE DUODENECTOMY (PSD) FOR
DUODENAL ADENOMA
J. A. Stauffer and H. J. Asbun
Mayo Clinic, Jacksonville, FL
The video submission is a case presentation of a 65-year-old
female who was found to have a circumferential adenoma of
the infra-ampullary duodenum. She was taken to surgery and
underwent a laparoscopic partial sleeve duodenectomy
(PSD). The video shows technical considerations and steps
of laparoscopic PSD. Laparoscopic PSD spares resection of
the head of the pancreas by separating the duodenum from
the head of the pancreas under direct magnified vision.
Intraoperative upper endoscopy was performed to ensure
complete adenoma removal and patency of the ampulla prior
to transection of the duodenum just distal to the ampulla.
Reconstruction was performed with a side to side
duodenojejunostomy. The patient was found to have a 5-cm
tubulovillous adenoma with high grade dysplasia and recov-
ered without any complications.
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10:30AM–12:30PM
PARALLEL MINI ORAL A
LIVER/TRANSPLANT
MO-A.01 OVERALL SURVIVAL BY
PATTERN OF RECURRENCE
FOLLOWING CURATIVE INTENT
SURGERY FOR COLORECTAL LIVER
METASTASIS
A. N. Kulaylat, J. R. Schubart, A. L. Stokes, E. T. Kimchi,
K. F. Staveley-O’Carroll, N. J. Bhayani, J. T. Kaifi and
N. J. Gusani
Section of Surgical Oncology, Penn State Hershey Cancer
Institute, Hershey, PA
Introduction: Following curative intent surgery (CIS) for
colorectal liver metastasis (CRLM), patterns of recurrence
and subsequent survival outcomes are not widely reported.
Methods: An institutional database (January 2002-
December 2012) was reviewed to evaluate patterns of recur-
rence following CIS for CRLM.
Results: 183 patients with CRLM underwent CIS (liver
resection, ablation, or both). Median follow-up and
progression-free survival (PFS) was 28 and 16 months,
respectively. 5-year overall survival (OS) was 51%. After
initial CIS, 102 (56%) patients recurred: 44% liver (5-year
OS 55%), 15% lung (5-year OS 45%), and 41% other/
multifocal (5-year OS 20%). While OS for liver vs. lung was
not significantly different, both were better compared to
other/multifocal (p = 0.018 for liver vs. other, p = 0.086 for
lung vs. other). Wider liver resection margins reduced the
risk of general (RR 0.95, p = 0.018) and isolated liver (RR
0.93, p = 0.043) recurrence. Other/multifocal recurrence was
more likely with extrahepatic disease at time of liver resec-
tion (RR 7.83, p = 0.045) and bilateral liver metastasis (RR
3.61, p = 0.041), but less likely with staged resections
(RR 0.11, p = 0.016), and increasing liver resection margin
(RR 0.90, p = 0.012). Of 102 1st recurrences, 53 patients were
able to undergo repeat CIS (in 71% liver recurrences, 67%
lung, and 24% other/multifocal). When repeat CIS was pos-
sible, 5-yr OS was 67%.
Conclusion: Patients with liver- or lung-only recurrences
after CIS for CRLM have high rates of repeat CIS and excel-
lent survival. Repeat CIS offers improved survival and
should be pursued where possible.
MO-A.02 INTRA-OPERATIVE LIVER
BIOPSY PATHOLOGY IN PATIENTS
UNDERGOING WEIGHT LOSS SURGERY
A. Dan1,3, M. Subichin1,3, J. Clanton1,3, M. Makuszewski3,
A. Bohon3, M. Pozsgay1,3, R. Shenoy1, S. M. Thompson2,3,
A. Venkataramani4, C. Sievers4 and J. Zografakis1,3
1Summa Health System Department Of Surgery, Akron,
OH; 2Summa Health System Department Of Pathology,
Akron, OH; 3Northeast Ohio Medical University,
Rootstown, OH; 4Summa Health System Department Of
Gastroenterology, Akron, OH
Introduction: The incidence of liver disease in the morbidly
obese varies, but most studies to date are small series. To
determine the degree of liver pathology at the time of weight
loss surgery, liver biopsy is often performed. We sought to
review the utility of routine liver biopsy and determine the
frequency of abnormal liver pathology in a large sample of
morbidly obese patients.
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